Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03400293 · ClinicalTrials.gov registry record
Real-world Insights of People With Human Immunodeficiency Virus (HIV) Infection
A clinical trial of HIV Infections, sponsored by ViiV Healthcare.
- Completed
- Registry status
- 1,184
- Enrollment target
- 1
- Study location
NCT03400293: Completed study of HIV Infections, sponsored by ViiV Healthcare.
NCT03400293 is a study of HIV Infections that has completed, run by ViiV Healthcare. The registered enrollment target is 1,184 participants, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (167% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03400293, a study of HIV Infections, has completed, sponsored by ViiV Healthcare.
- COMPLETED
- Registry status
- 1,184 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to identify the burden associated with HIV and its treatment, and assess their health-related quality of life (HRQoL) by measuring key HRQoL domains, including satisfaction with treatment and care, and internalised stigma (ISAT). The study will also explore data for various important subpopulations such as subjects who are virally suppressed; who we anticipate will be the majority of study subjects. The study design is an observational, cross sectional study employing subjects' own mobile phone devices for data entry.
Primary Outcome
Evaluation of HRQoL will be conducted using scores achieved by Functional Assessment of HIV Infection (FAHI). QoL assessment will include physical well-being, social well-being, emotional well-being, functional and global well-being, and cognitive functioning
Conditions Studied
Interventions
- OTHER Functional Assessment of HIV Infection
- OTHER Patient Satisfaction Questionnaire
- OTHER Symptom Distress Module
- OTHER Patient Health Questionnaire
- OTHER Internalized Stigma of AIDS Tool
Study Locations (1)
Virginia
- GSK Investigational Site - Arlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,184 participants |
| Start Date | 2018-01-18 |
| Est. Completion | 2018-07-07 |
What the finished NCT03400293 record still lists
NCT03400293 is an observational study that tracks outcomes without assigning an intervention. Its 1,184 participants enrollment target places it among the larger protocols in the corpus, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (167% higher).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 5 interventions - of which Functional Assessment of HIV Infection is the first listed.
NCT03400293 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03400293 about?
NCT03400293 is a clinical study titled "Real-world Insights of People With Human Immunodeficiency Virus (HIV) Infection". This study is designed to identify the burden associated with HIV and its treatment, and assess their health-related quality of life (HRQoL) by measuring key HRQoL domains, including satisfaction with treatment and care, and internalised stigma (ISAT). The study will also explore data for various im...
What is the current status of trial NCT03400293?
This trial is currently completed. The enrollment target is 1,184 participants. The study started on 2018-01-18. Estimated completion is 2018-07-07.
What conditions does trial NCT03400293 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT03400293?
The interventions under investigation include: Functional Assessment of HIV Infection (OTHER), Patient Satisfaction Questionnaire (OTHER), Symptom Distress Module (OTHER), Patient Health Questionnaire (OTHER), Internalized Stigma of AIDS Tool (OTHER).
Who is sponsoring clinical trial NCT03400293?
This trial is sponsored by ViiV Healthcare, which has 182 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03400293 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03400293's enrollment target sits among peer trials
1,184 24th of 542 higher than 519 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT07286058 · 1,182 participants · Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- NCT05580419 · 1,188 participants · NA
Impact of 4PCP on Practitioner and Patient Outcomes
- NCT06290869 · 1,188 participants · Phase 3
Tobacco Education and Lung Health Study (TEAL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI